MUSTANG BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$2.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$3.00K, a 127.27% decline year-over-year.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$50.00K, a 143.10% decline year-over-year.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$12.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$90.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$586.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.09M, a 208.55% decline from fiscal 2022.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.01M, a 150.87% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.00K 10-Q · filed 2026-08-05 | -$55.00K derived: sum of 3 quarters · filed 2026-08-05 | -$67.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$3.00K 10-Q · filed 2026-05-05 | -$53.00K derived: sum of 2 quarters · filed 2026-05-05 | -$65.00K derived: sum of 3 quarters · filed 2026-05-05 | -$104.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$62.00K derived: sum of 2 quarters · filed 2026-03-19 | -$101.00K derived: sum of 3 quarters · filed 2026-08-05 | -$90.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$51.00K derived: sum of 2 quarters · filed 2026-08-05 | -$40.00K 10-Q · filed 2025-11-07 | $76.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$28.00K 10-Q · filed 2026-08-05 | $88.00K derived: sum of 3 quarters · filed 2026-08-05 | $58.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-05 | $127.00K derived: sum of 2 quarters · filed 2026-05-05 | $97.00K derived: sum of 3 quarters · filed 2026-05-05 | -$204.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $86.00K derived: sum of 2 quarters · filed 2026-03-19 | -$215.00K derived: sum of 3 quarters · filed 2026-03-19 | -$586.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$331.00K derived: sum of 2 quarters · filed 2025-11-07 | -$702.00K 10-Q · filed 2025-11-07 | -$3.48M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$672.00K 10-Q · filed 2025-08-08 | -$3.45M derived: sum of 3 quarters · filed 2025-08-08 | -$1.44M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$371.00K 10-Q · filed 2025-05-14 | -$3.15M derived: sum of 2 quarters · filed 2025-05-14 | -$1.14M derived: sum of 3 quarters · filed 2025-05-14 | -$1.33M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$767.00K derived: sum of 2 quarters · filed 2025-03-28 | -$961.00K derived: sum of 3 quarters · filed 2025-03-28 | -$1.09M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.82M derived: sum of 2 quarters · filed 2024-11-08 | $1.69M 10-Q · filed 2024-11-08 | $1.72M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$325.00K 10-Q · filed 2024-08-13 | -$289.00K derived: sum of 3 quarters · filed 2024-08-13 | $748.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$131.00K 10-Q · filed 2024-05-15 | -$95.00K derived: sum of 2 quarters · filed 2024-05-15 | $942.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.08M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.07M derived: sum of 2 quarters · filed 2024-03-11 | $1.22M derived: sum of 3 quarters · filed 2024-03-11 | $1.01M 10-K · filed 2024-03-11 | $1.02M 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.18M derived: sum of 2 quarters · filed 2023-11-14 | $970.00K 10-Q · filed 2023-11-14 | $2.09M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$67.00K 10-Q · filed 2023-08-14 | $1.05M derived: sum of 3 quarters · filed 2023-08-14 | $658.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$209.00K 10-Q · filed 2023-05-12 | $909.00K derived: sum of 2 quarters · filed 2023-05-12 | $516.00K derived: sum of 3 quarters · filed 2023-05-12 | $321.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $725.00K derived: sum of 2 quarters · filed 2023-03-30 | $530.00K derived: sum of 3 quarters · filed 2023-03-30 | $401.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$588.00K derived: sum of 2 quarters · filed 2022-11-14 | -$717.00K 10-Q · filed 2022-11-14 | $961.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$324.00K 10-Q · filed 2022-08-11 | $1.35M derived: sum of 3 quarters · filed 2022-08-11 | $1.37M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$129.00K 10-Q · filed 2022-05-12 | $1.55M derived: sum of 2 quarters · filed 2022-05-12 | $1.56M derived: sum of 3 quarters · filed 2022-05-12 | -$291.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.69M derived: sum of 2 quarters · filed 2022-03-23 | -$162.00K derived: sum of 3 quarters · filed 2022-03-23 | $84.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.84M derived: sum of 2 quarters · filed 2021-11-12 | -$1.59M 10-Q · filed 2021-11-12 | -$1.48M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$1.61M 10-Q · filed 2021-08-16 | -$1.49M derived: sum of 3 quarters · filed 2021-08-16 | -$635.00K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $246.00K 10-Q · filed 2021-05-14 | $364.00K derived: sum of 2 quarters · filed 2021-05-14 | $1.22M derived: sum of 3 quarters · filed 2021-05-14 | $1.07M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $971.00K derived: sum of 2 quarters · filed 2021-03-24 | $823.00K derived: sum of 3 quarters · filed 2021-03-24 | $558.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $705.00K derived: sum of 2 quarters · filed 2020-11-06 | $440.00K 10-Q · filed 2020-11-06 | $460.00K derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$413.00K 10-Q · filed 2020-08-10 | -$393.00K derived: sum of 3 quarters · filed 2020-08-10 | -$613.00K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$265.00K 10-Q · filed 2020-05-11 | -$245.00K derived: sum of 2 quarters · filed 2020-05-11 | -$465.00K derived: sum of 3 quarters · filed 2020-05-11 | -$239.00K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$200.00K derived: sum of 2 quarters · filed 2020-03-16 | $26.00K derived: sum of 3 quarters · filed 2020-03-16 | $757.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $6.00K derived: sum of 2 quarters · filed 2019-11-12 | $737.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $957.00K 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $731.00K 10-Q · filed 2018-05-14 | ||||
| 2017-09-30 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $399.00K derived: sum of 2 quarters · filed 2018-11-13 | $414.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $8.00K 10-Q · filed 2018-08-13 | |||
| 2017-03-31 | $15.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |